Facebook
Twitter
Telegram
Report an ErrorCumberland Pharmaceuticals Financial Ratios 2011-2024 | CPIX
Annual Financial Ratios Cumberland Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-13.1 | -13.0 | -14.3 | -21.5 | -12.2 | -13.8 | -107.9 | 113.4 | 42.2 | -42.0 | 14.3 | 21.8 |
P/S |
3.5 | 6.0 | 1.3 | 1.6 | 2.1 | 2.7 | 3.1 | 2.5 | 2.8 | 2.8 | 1.7 | 2.4 |
EPS |
-0.2 | -0.3 | -0.2 | -0.2 | -0.5 | -0.5 | -0.1 | 0.0 | 0.1 | -0.1 | 0.3 | 0.3 |
EV (Enterprise Value) |
69.2 M | 64.9 M | 72.5 M | 101 M | 114 M | 94.3 M | 87.7 M | 59.8 M | 77.1 M | 55.8 M | 42.2 M | 65.6 M |
EBITDA per Share |
0.21 | 0.02 | -0.13 | 0.0332 | -0.296 | -0.103 | 0.0469 | 0.186 | 0.293 | -0.158 | 0.475 | 0.522 |
EV/EBITDA |
-19.4 | -20.6 | 130.0 | -16.7 | -45.5 | 94.0 | 15.0 | 12.1 | -16.3 | 3.6 | 5.4 | |
PEG |
-0.16 | 0.08 | -2.51 | -0.44 | -1.22 | 0.02 | 0.46 | -1.66 | 0.19 | 0.31 | 1.94 | 0.17 |
P/B |
0.9 | 1.2 | 1.0 | 1.5 | 1.5 | 1.7 | 1.4 | 1.1 | 1.3 | 1.1 | 1.0 | 1.5 |
P/CF |
3.8 | 7.9 | 14.4 | 37.4 | -73.1 | -54.0 | -65.3 | 26.1 | 29.9 | -13.0 | 18.2 | 14.9 |
ROE % |
-6.73 | -8.99 | -7.12 | -6.93 | -12.53 | -12.48 | -1.29 | 0.95 | 3.00 | -2.65 | 6.83 | 6.83 |
ROA % |
-2.63 | -4.56 | -3.46 | -3.38 | -6.18 | -8.56 | -1.01 | 0.80 | 2.54 | -2.40 | 5.93 | 5.92 |
ROCE % |
-6.28 | -10.17 | -9.01 | -4.51 | -8.71 | -5.40 | -1.82 | 1.40 | 4.36 | -4.75 | 9.74 | 11.20 |
Current Ratio |
1.6 | 2.0 | 1.9 | 2.1 | 2.1 | 3.9 | 4.4 | 5.4 | 5.2 | 9.1 | 10.8 | 13.2 |
DSO |
400.9 | 422.4 | 120.7 | 75.1 | 70.3 | 74.5 | 81.0 | 66.2 | 54.4 | 51.6 | 45.0 | 50.5 |
DIO |
366.1 | 394.9 | 448.7 | 392.5 | 597.5 | 333.7 | 329.0 | 313.7 | 404.5 | 384.0 | 449.8 | 393.1 |
DPO |
409.5 | 477.2 | 565.1 | 496.8 | 548.8 | 444.7 | 492.3 | 211.4 | 234.2 | 136.6 | 201.8 | 103.0 |
Operating Cycle |
767.0 | 817.3 | 569.4 | 467.6 | 667.8 | 408.1 | 410.1 | 379.9 | 459.0 | 435.7 | 494.7 | 443.6 |
Cash Conversion Cycle |
357.5 | 340.2 | 4.3 | -29.2 | 119.0 | -36.6 | -82.2 | 168.5 | 224.7 | 299.0 | 292.9 | 340.6 |
All numbers in USD currency
Quarterly Financial Ratios Cumberland Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.07 | 0.06 | 0.01 | - | -0.03 | -0.09 | -0.09 | -0.26 | -0.07 | 0.08 | 0.01 | -0.06 | -0.03 | -0.06 | -0.07 | -0.06 | -0.13 | -0.13 | - | -0.14 | -0.11 | -0.05 | -0.15 | -0.05 | -0.05 | -0.32 | -0.08 | -0.05 | 0.01 | - | -0.02 | 0.01 | 0.01 | 0.02 | - | 0.04 | 0.04 | 0.04 | 0.02 | -0.08 | -0.04 | -0.03 | 0.05 | 0.09 | 0.1 | 0.09 | 0.02 | 0.05 | 0.09 | 0.11 | 0.04 |
EBITDA per Share |
-0.05 | 0.08 | -0.02 | - | 0.08 | -0.02 | 0.02 | -0.3 | 0.13 | 0.07 | 0.06 | -0.12 | 0.15 | 0.05 | -0.05 | -0.22 | -0.14 | 0.01 | -0.02 | -0.21 | -0.03 | -0.03 | -0.17 | -0.06 | 0.07 | -0.02 | - | -0.06 | 0.12 | 0.07 | - | 0.01 | 0.12 | 0.11 | 0.03 | 0.06 | 0.14 | 0.11 | 0.04 | -0.14 | -0.03 | -0.03 | 0.09 | 0.17 | 0.19 | 0.12 | 0.04 | 0.09 | 0.19 | 0.2 | 0.08 |
ROE % |
-1.14 | 0.72 | -5.03 | -7.90 | -16.88 | -18.09 | -12.13 | -8.38 | -1.28 | -0.04 | -4.55 | -7.11 | -7.11 | -9.86 | -11.72 | -9.61 | -11.71 | -10.87 | -8.34 | -12.47 | -9.74 | -7.96 | -14.72 | -12.44 | -12.22 | -10.91 | -2.93 | -1.29 | -0.07 | -0.05 | 0.55 | 0.95 | 1.58 | 2.34 | 2.71 | 3.00 | 0.28 | -1.67 | -3.37 | -2.65 | 1.35 | 4.56 | 7.40 | 6.82 | 5.81 | 5.86 | 6.45 | 6.82 | 2.23 | 2.63 | 0.87 |
ROA % |
-0.48 | 0.27 | -2.15 | -3.34 | -7.90 | -8.65 | -5.83 | -4.23 | -0.59 | 0.12 | -2.21 | -3.46 | -3.46 | -4.85 | -5.76 | -4.73 | -5.79 | -5.36 | -4.13 | -6.18 | -5.07 | -4.41 | -9.30 | -8.56 | -8.50 | -7.59 | -2.11 | -1.01 | -0.04 | -0.02 | 0.47 | 0.80 | 1.33 | 1.98 | 2.29 | 2.54 | 0.13 | -1.59 | -3.08 | -2.40 | 1.14 | 3.97 | 6.47 | 5.93 | 5.05 | 5.09 | 5.60 | 5.92 | 1.93 | 2.28 | 0.75 |
ROCE % |
-10.12 | -5.67 | -10.44 | -8.62 | -18.79 | -21.40 | -19.69 | -17.22 | -10.76 | -9.98 | -10.34 | -13.58 | -16.50 | -20.11 | -23.00 | -21.46 | -20.72 | -19.27 | -16.46 | -20.01 | -15.52 | -12.09 | -11.28 | -6.37 | -6.26 | -4.78 | -2.30 | -1.96 | -0.44 | -0.26 | 0.76 | 1.45 | 2.41 | 3.28 | 3.91 | 4.41 | 0.12 | -3.01 | -5.95 | -4.78 | 2.12 | 7.51 | 11.20 | 10.29 | 8.56 | 8.82 | 10.93 | 11.88 | 3.74 | 4.38 | 1.70 |
Current Ratio |
1.7 | 1.7 | 1.7 | 1.6 | 1.7 | 1.7 | 1.7 | 2.0 | 2.1 | 2.2 | 2.0 | 1.9 | 1.9 | 1.9 | 1.9 | 2.0 | 2.0 | 2.0 | 1.9 | 2.0 | 2.0 | 2.0 | 2.0 | 3.2 | 3.2 | 3.2 | 3.2 | 4.6 | 4.6 | 4.6 | 4.6 | 6.1 | 6.1 | 6.1 | 6.1 | 6.5 | 6.5 | 6.5 | 6.5 | 10.5 | 10.5 | 10.5 | 10.5 | 7.6 | 7.6 | 7.6 | 7.6 | 7.5 | 7.5 | 7.5 | 7.5 |
DSO |
112.4 | 112.1 | 137.0 | - | 114.0 | 123.7 | 87.8 | 91.7 | 107.4 | 109.3 | 107.9 | 110.1 | 122.1 | 117.7 | 110.8 | 79.2 | 106.2 | 86.3 | 85.9 | 62.2 | 122.3 | 70.4 | 86.3 | 65.8 | 68.4 | 88.4 | 74.5 | 73.7 | 76.1 | 90.2 | 79.1 | 69.0 | 70.3 | 62.2 | 60.8 | 53.8 | 51.6 | 51.5 | 56.6 | 50.7 | 63.3 | 58.4 | 46.9 | 40.1 | 43.8 | 44.4 | 58.3 | 49.6 | 49.5 | 44.9 | - |
DIO |
506.5 | 633.3 | 731.4 | - | 411.6 | 433.4 | 377.6 | - | 699.7 | 527.2 | 389.7 | - | 453.0 | 371.9 | 544.7 | - | 540.8 | 182.5 | 578.8 | - | 754.7 | 723.5 | 561.9 | - | 283.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
561.5 | 664.1 | 804.3 | - | 453.3 | 494.9 | 435.0 | - | 625.1 | 509.3 | 450.4 | - | 570.5 | 468.4 | 653.0 | - | 525.9 | 174.9 | 481.4 | - | 693.1 | 664.5 | 599.4 | - | 378.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
618.8 | 745.4 | 868.4 | - | 525.6 | 557.0 | 465.5 | 91.7 | 807.1 | 636.6 | 497.7 | 110.1 | 575.1 | 489.6 | 655.5 | 79.2 | 647.0 | 268.9 | 664.7 | 62.2 | 876.9 | 794.0 | 648.1 | 65.8 | 352.2 | 88.4 | 74.5 | 73.7 | 76.1 | 90.2 | 79.1 | 69.0 | 70.3 | 62.2 | 60.8 | 53.8 | 51.6 | 51.5 | 56.6 | 50.7 | 63.3 | 58.4 | 46.9 | 40.1 | 43.8 | 44.4 | 58.3 | 49.6 | 49.5 | 44.9 | - |
Cash Conversion Cycle |
57.3 | 81.3 | 64.1 | - | 72.2 | 62.1 | 30.5 | 91.7 | 181.9 | 127.3 | 47.3 | 110.1 | 4.7 | 21.2 | 2.5 | 79.2 | 121.0 | 94.0 | 183.3 | 62.2 | 183.8 | 129.4 | 48.7 | 65.8 | -26.0 | 88.4 | 74.5 | 73.7 | 76.1 | 90.2 | 79.1 | 69.0 | 70.3 | 62.2 | 60.8 | 53.8 | 51.6 | 51.5 | 56.6 | 50.7 | 63.3 | 58.4 | 46.9 | 40.1 | 43.8 | 44.4 | 58.3 | 49.6 | 49.5 | 44.9 | - |
All numbers in USD currency